BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10047775)

  • 1. Low DNA repair is a risk factor in skin carcinogenesis: a study of basal cell carcinoma in psoriasis patients.
    Dybdahl M; Frentz G; Vogel U; Wallin H; Nexø BA
    Mutat Res; 1999 Jan; 433(1):15-22. PubMed ID: 10047775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psoriasis patients with basal cell carcinoma have more repair-mediated DNA strand-breaks after UVC damage in lymphocytes than psoriasis patients without basal cell carcinoma.
    Møller P; Wallin H; Dybdahl M; Frentz G; Nexø BA
    Cancer Lett; 2000 Apr; 151(2):187-92. PubMed ID: 10738113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seasonal variation of DNA damage and repair in patients with non-melanoma skin cancer and referents with and without psoriasis.
    Møller P; Knudsen LE; Frentz G; Dybdahl M; Wallin H; Nexø BA
    Mutat Res; 1998 Feb; 407(1):25-34. PubMed ID: 9539978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultraviolet exposure as the main initiator of p53 mutations in basal cell carcinomas from psoralen and ultraviolet A-treated patients with psoriasis.
    Seidl H; Kreimer-Erlacher H; Bäck B; Soyer HP; Höfler G; Kerl H; Wolf P
    J Invest Dermatol; 2001 Aug; 117(2):365-70. PubMed ID: 11511317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA repair capacity as a risk factor for non-melanocytic skin cancer--a molecular epidemiological study.
    Hall J; English DR; Artuso M; Armstrong BK; Winter M
    Int J Cancer; 1994 Jul; 58(2):179-84. PubMed ID: 8026878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in the DNA repair gene XPD: correlations with risk and age at onset of basal cell carcinoma.
    Dybdahl M; Vogel U; Frentz G; Wallin H; Nexø BA
    Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):77-81. PubMed ID: 9950243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA repair related to multiple skin cancers and drug use.
    Wei Q; Matanoski GM; Farmer ER; Hedayati MA; Grossman L
    Cancer Res; 1994 Jan; 54(2):437-40. PubMed ID: 8275480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors that influence the DNA repair capacity of normal and skin cancer-affected individuals.
    D'Errico M; Calcagnile A; Iavarone I; Sera F; Baliva G; Chinni LM; Corona R; Pasquini P; Dogliotti E
    Cancer Epidemiol Biomarkers Prev; 1999 Jun; 8(6):553-9. PubMed ID: 10385147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA repair and aging in basal cell carcinoma: a molecular epidemiology study.
    Wei Q; Matanoski GM; Farmer ER; Hedayati MA; Grossman L
    Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1614-8. PubMed ID: 8434025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of the DNA repair gene XPD: correlations with risk of basal cell carcinoma revisited.
    Vogel U; Hedayati M; Dybdahl M; Grossman L; Nexø BA
    Carcinogenesis; 2001 Jun; 22(6):899-904. PubMed ID: 11375896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study.
    Stern RS; Liebman EJ; Väkevä L
    J Natl Cancer Inst; 1998 Sep; 90(17):1278-84. PubMed ID: 9731734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA repair capacity for ultraviolet light-induced damage is reduced in peripheral lymphocytes from patients with basal cell carcinoma.
    Wei Q; Matanoski GM; Farmer ER; Hedayati MA; Grossman L
    J Invest Dermatol; 1995 Jun; 104(6):933-6. PubMed ID: 7769261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen + ultraviolet a light-treated psoriasis patients.
    Katz KA; Marcil I; Stern RS
    J Invest Dermatol; 2002 Jun; 118(6):1038-43. PubMed ID: 12060400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repair capacity for UV light induced DNA damage associated with risk of nonmelanoma skin cancer and tumor progression.
    Wang LE; Li C; Strom SS; Goldberg LH; Brewster A; Guo Z; Qiao Y; Clayman GL; Lee JJ; El-Naggar AK; Prieto VG; Duvic M; Lippman SM; Weber RS; Kripke ML; Wei Q
    Clin Cancer Res; 2007 Nov; 13(21):6532-9. PubMed ID: 17975167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The XPC poly-AT polymorphism in non-melanoma skin cancer.
    Nelson HH; Christensen B; Karagas MR
    Cancer Lett; 2005 May; 222(2):205-9. PubMed ID: 15863269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twelve single nucleotide polymorphisms on chromosome 19q13.2-13.3: linkage disequilibria and associations with basal cell carcinoma in Danish psoriatic patients.
    Yin J; Vogel U; Gerdes LU; Dybdahl M; Bolund L; Nexø BA
    Biochem Genet; 2003 Feb; 41(1-2):27-37. PubMed ID: 12645871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA repair and susceptibility to basal cell carcinoma: a case-control study.
    Wei Q; Matanoski GM; Farmer ER; Hedayati MA; Grossman L
    Am J Epidemiol; 1994 Oct; 140(7):598-607. PubMed ID: 7942760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA repair and epidemiology of basal cell carcinoma.
    Grossman L; Wei Q
    Clin Chem; 1995 Dec; 41(12 Pt 2):1854-63. PubMed ID: 7497645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultraviolet damage, DNA repair and vitamin D in nonmelanoma skin cancer and in malignant melanoma: an update.
    Reichrath J; Rass K
    Adv Exp Med Biol; 2014; 810():208-33. PubMed ID: 25207368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and field-test validation of an assay for DNA repair in circulating human lymphocytes.
    Athas WF; Hedayati MA; Matanoski GM; Farmer ER; Grossman L
    Cancer Res; 1991 Nov; 51(21):5786-93. PubMed ID: 1933849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.